Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00089440 |
The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.
Condition | Intervention | Phase |
---|---|---|
Amphetamine-Related Disorders |
Drug: Aripiprazole |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Placebo Control |
Official Title: | Assessment of Interactions Between IV Methamphetamine and Aripiprazole |
Estimated Enrollment: | 17 |
Study Start Date: | June 2004 |
Estimated Study Completion Date: | March 2005 |
This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
UCLA Integrated Substance Abuse Program | |
Los Angeles, California, United States, 90024 | |
United States, New York | |
New York University, School of Medicine | |
New York, New York, United States, 10016 |
Principal Investigator: | Thomas Newton, M.D. | University of California, Los Angeles |
Study ID Numbers: | NIDA-MDS-0002-1 |
Study First Received: | August 5, 2004 |
Last Updated: | October 25, 2007 |
ClinicalTrials.gov Identifier: | NCT00089440 |
Health Authority: | United States: Food and Drug Administration |
Methamphetamine Dopamine Mental Disorders Amphetamine-Related Disorders |
Substance-Related Disorders Disorders of Environmental Origin Amphetamine Aripiprazole |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Tranquilizing Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Sympathomimetics Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs |
Central Nervous System Depressants Central Nervous System Stimulants Antipsychotic Agents Pharmacologic Actions Autonomic Agents Therapeutic Uses Dopamine Agents Peripheral Nervous System Agents Central Nervous System Agents |